Companies
AS
NikkeiHealth Care· Japan
4503
Astellas Pharma
$2,553.50
-1.22%
Open $2,557.00·Prev $2,585.00
as of 17 Apr
ANALYSIS PENDING
Power Core
Structural analysis in progress
Published—
UniverseNikkei 225
SectorHealth Care
—
Direction of Movement
---
ROC 200
+82.7%
4503
Astellas Pharma
$2,553.50
-1.22%
Open $2,557.00·Prev $2,585.00
as of 17 Apr
↑Undervalued by 83%
DCF Fair Value: $15,430.88
Analysis Coming Q3/Q4 2026
News
No recent news available.
mOS zones are proprietary L17X overlays and do not constitute trading signals or investment advice.